Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Imarx Therapeutics Inc (IMRX) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Imarx Therapeutics Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1123695.
Total stock buying since 2010: $408,684.
Total stock sales since 2010: $0.
Total stock option exercises since 2010: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2010 | 51,085,568 | $408,684 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2010-05 | 51,085,568 | $408,684 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2010-05-28 | Takats Joseph Richard (Senior Exec. VP (Marketing)) | Buy | 25,542,784 | .01 | 204,342 |
| 2010-05-28 | Scotti Donald James (President) | Buy | 25,542,784 | .01 | 204,342 |
Insider trading activities including stock purchases, stock sales, and option exercises of IMRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Imarx Therapeutics Inc (symbol IMRX, CIK number 1123695) see the Securities and Exchange Commission (SEC) website.